Janel (JANL) Valuation Rank

View and export this data going back to . Start your Free Trial

What is Janel Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Janel Valuation Rank Related Terms

Thank you for viewing the detailed overview of Janel's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Janel Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Janel Corp (OTCPK:JANL) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Eighth Avenue, New York, NY, USA, 10011

Website

https://www.janelcorp.com

Janel Corp is a holding company. The company's operating segments include Logistics Services, Manufacturing, and Life Sciences. The logistics Services segment is a full-service provider of cargo transportation logistics management services, including freight forwarding via air, ocean, land-based carriers, customs brokerage services, warehousing, and distribution services. The Manufacturing segment manufactures and distributes industrial mixing equipment and apparatus for specific applications within various industries. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research. It generates maximum revenue from the Logistics Services segment.

Executives

Gregory B Graves	director	129 CONCORD ROAD, BILLERICA MA 01821
Gonzalez John Joseph Ii	10 percent owner, officer: SR Managing Director NE Region	7 PARSONS LANDING, ISLIP NY 11751
Kesteren Gerard Van	director	80 EIGHTH AVENUE, NEW YORK NY 10011
Dominique Schulte	10 percent owner	68 BANK STREET, NEW YORK NY 10014
Brendan James Killackey	director	80 EIGHTH AVENUE, NEW YORK NY 10011
Oaxaca Group L.l.c.	10 percent owner	68 BANK STREET, NEW YORK NY 10014
Vincent Verde	officer: CFO	C/O JANEL CORPORATION, 303 MERRICK ROAD, SUITE 400, LYNBROOK NY 11563
Ryan Karen Miller	director	2260 S ADAMS, DENVER CO 80210
John Eidinger	10 percent owner	80 EIGHTH AVENUE, NEW YORK NY 10011
Gregory J Melsen	director	614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
James N Jannello	10 percent owner	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563
Carlos Pla	officer: CFO	303 MERRICK ROAD, SUITE 400, LYNBROOK NY 11563
Brian Aronson	officer: CFO	745 BOULEVARD EAST, WEEHAWKEN NJ 07086
Nicholas V Ferrara	director	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563
Philip J Dubato	officer: EVP of Finance	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563